I wonder how much halo effect keytruda will have from lung to other indications opdivo data seem at least as good as keytruda in melanoma IMO BMY has their nivo/ipi combination in adjuvant setting now fully enrolled which could provide an edge if successful
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.